SnagRx vs Telos Rx: Compounded Semaglutide Price and Service
Quick verdict: For lowest advertised annual-plan price and a lifetime price lock at every dose, SnagRx leads; Telos Rx lists higher starting rates and emphasizes plan-dependent pricing and clinician approval. This comparison looks at price, pricing terms, medication type, clinician review and state coverage for SnagRx vs Telos Rx.
Price and pricing structure
SnagRx: compounded semaglutide from $69/month on the 12-month plan and $99/month month-to-month. SnagRx states the $69 and $119 figures are the 12-month plan rates and that the rate is locked flat at every dose and at renewal. Telos Rx: lists semaglutide as low as $99 per month and tirzepatide as low as $139 per month. Telos Rx wording ties price to the live offer and to plan details, stating your price depends on your plan and a licensed provider must approve you.
Medication type and regulatory note
Both providers offer compounded semaglutide and compounded tirzepatide only. Both sources explicitly state compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality. SnagRx notes its compounding is done by named US 503A pharmacies. Telos Rx states medications are compounded and prescription only, subject to medical approval.
Clinician review, eligibility and state coverage
SnagRx operates with a clinician network, OpenLoop Health, and states clinicians typically review intake within five hours and always within 24. SnagRx says OpenLoop clinicians cover 48 states. Telos Rx requires review by a US licensed provider and emphasizes that treatment is available only when a licensed clinician determines it is medically appropriate. Telos Rx captures fewer verification details on state coverage in the supplied capture. Both emphasize clinician approval before prescription.
Shipping, fulfillment and refund terms
SnagRx advertises next-day UPS or FedEx shipping in temperature controlled packaging and a full refund if the prescription is declined. Telos Rx captured details do not include specific shipping time claims in the supplied evidence. Both providers include the clinician review and prescription process as part of their offerings.
Most distinctive differences at a glance
| Criteria | SnagRx | Telos Rx |
|---|---|---|
| Starting semaglutide price | From $69/month on 12-month plan | As low as $99/month |
| Price lock or renewal terms | Price locked flat at every dose and at renewal | Price depends on plan; terms may change |
| Medication type | Compounded semaglutide and tirzepatide | Compounded semaglutide and tirzepatide |
| Clinician review speed and network | OpenLoop Health clinicians; review typically within 5 hours; covers 48 states | Licensed provider review required; availability subject to live offer and clinician approval |
| Fulfillment details | Named US 503A pharmacies; next-day shipping; temperature controlled | Captured evidence did not verify specific fulfillment partners or shipping times |
Evidence-based pros and cons compared
SnagRx pros from the supplied evidence include bottom-of-market annual-plan pricing on the 12-month option, a stated lifetime price lock at every dose, named US 503A partner pharmacies, and claims of quick clinician review and next-day shipping. Cons include that the low rates require a 12-month commitment, medications are compounded only, clinician coverage is 48 states not all 50, and the source captures urgency marketing on the pricing page.
Telos Rx evidence highlights semaglutide from $99/month and tirzepatide from $139/month as live offers and stresses that pricing, eligibility, pharmacy and renewal terms may change. The supplied capture does not publish expanded FAQ answers or detailed shipping and pharmacy partner information.
How SnagRx vs Telos Rx differ most
Three to five distinctive differences supported by the source are clear: starting price on the annual plan and the existence of a price lock for SnagRx; named compounding pharmacies and an identified clinician network for SnagRx versus Telos Rx, which ties price and availability to the live offer and plan; clinician coverage detail and review timing for SnagRx versus Telos Rx emphasis on plan dependent approval; and documented next-day shipping claims for SnagRx while Telos Rx capture lacks verified shipping particulars.
Conclusion: SnagRx vs Telos Rx
SnagRx offers lower advertised annual-plan pricing at $69/month for compounded semaglutide and an explicit price lock for the life of treatment, plus named 503A pharmacies and a stated clinician network. Telos Rx lists semaglutide as low as $99/month and frames pricing and availability as dependent on plan and live offer, with clinician approval required. Both deliver compounded medications and both state compounded products are not FDA approved.
Choose SnagRx if you prioritize a lower 12-month rate, a stated price lock at every dose, named pharmacy partners and a documented clinician network. Choose Telos Rx if you prefer a provider whose published capture emphasizes plan-dependent pricing and a live-offer model and you will confirm eligibility, costs and state availability before enrolling.